Search results
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga via Yahoo Finance· 56 minutes agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 31 minutes agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 47 minutes agoInc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 1 hour agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 2 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in ...
AstraZeneca pulls COVID-19 vaccine from global markets
UPI· 2 days agoAstraZeneca Wednesday said it was pulling its Vaxzevria COVID-19 vaccine pictured here from sale...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 1 day agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Wednesday's Health Report: Astrazeneca pulling COVID-19 vaccine, cites low demand
WBRZ 2 Baton Rouge· 2 hours agoBATON ROUGE — U.K.-based drug manufacturer Astrazeneca is pulling its COVID-19 vaccine globally. They cited low demand. The company said ...